Find similar content

Source channel @githubtrending · Post #14854 · Jun 23

#vue#courses_management_system#education#frappe#javascript#learning#learning_management_system#lms#online_course_platform#online_learning#open_source#python Frappe Learning is an easy-to-use, open-source Learning Management System that helps you create and organize courses with a clear structure of courses, chapters, and lessons. It supports live Zoom classes, quizzes, assignments, and certificates to track and reward learner progress. You can host it yourself or use managed hosting for easy setup and maintenance. Its drag-and-drop course builder and pre-built lessons simplify course creation, while features like notifications and discussion sections enhance interaction. This system helps you share knowledge effectively, monitor learner progress, and provide a smooth, engaging learning experience without complicated setups or high costs. https://github.com/frappe/lms

Hashtags

#vue #courses_management_system #education #frappe #javascript #learning #learning_management_system #lms #online_course_platform #online_learning #open_source #python

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment